Summary
memetis is an award-winning innovative SME, spin-off from Institute of Microstructure Technology (IMT) / Karlsruhe Institute of Technology (KIT) that designs modular fluidic platforms using Shape Memory Alloy (SMA) miniature valves for user specific needs. It enables the realization of unprecedented fluidic platforms in terms of outer dimensions, functionality, integration density and power consumption. Uses of the technology range from laboratory based tools to commercial applications like medical diagnostics.
Processes which are normally carried out in a lab can be miniaturized on a single chip and performed at the Point of Care/ Point of Need to enhance analysis, diagnostic efficiency and speed while reducing sample and reagent volumes. At the intersection of engineering, physics, chemistry, information technology, and biotechnology, memetis can revolutionize the way patients are diagnosed, monitored and treated. This solution has high disruptive potential and can be implemented across Europe and beyond to reach a large worldwide market.
Prototypes of various SMA miniature valves are already available. In the past year several pilot customers acquired paid developments and application-specific projects were transferred to series production (30,000 – 50,000 pieces). Currently, incoming 2018 orders are of low 6-digits providing a solid basis to achieve this year's turnover objective.
Our traction has already been substantial. Besides the EXIST Research Transfer Phase I grant, we have attracted equity investments and we have received the following awards: 1st place KIT Venture Fest Gründerpitch (Aug 2016), 1st place Elevator Pitch Baden-Württemberg (Jun 2017), Winner WECONOMY (Jun 2017), Init Innovation Prize Cyber Champions Award (Aug 2017), 2nd place CyberOne Hightech Award (Oct 2017) & 4th place at VC Pitch BW (Feb 2018). Further, we have qualified for the 2nd round of the CoHMed Connected Health
application process.
Processes which are normally carried out in a lab can be miniaturized on a single chip and performed at the Point of Care/ Point of Need to enhance analysis, diagnostic efficiency and speed while reducing sample and reagent volumes. At the intersection of engineering, physics, chemistry, information technology, and biotechnology, memetis can revolutionize the way patients are diagnosed, monitored and treated. This solution has high disruptive potential and can be implemented across Europe and beyond to reach a large worldwide market.
Prototypes of various SMA miniature valves are already available. In the past year several pilot customers acquired paid developments and application-specific projects were transferred to series production (30,000 – 50,000 pieces). Currently, incoming 2018 orders are of low 6-digits providing a solid basis to achieve this year's turnover objective.
Our traction has already been substantial. Besides the EXIST Research Transfer Phase I grant, we have attracted equity investments and we have received the following awards: 1st place KIT Venture Fest Gründerpitch (Aug 2016), 1st place Elevator Pitch Baden-Württemberg (Jun 2017), Winner WECONOMY (Jun 2017), Init Innovation Prize Cyber Champions Award (Aug 2017), 2nd place CyberOne Hightech Award (Oct 2017) & 4th place at VC Pitch BW (Feb 2018). Further, we have qualified for the 2nd round of the CoHMed Connected Health
application process.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/835339 |
| Start date: | 01-01-2019 |
| End date: | 30-06-2019 |
| Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
memetis is an award-winning innovative SME, spin-off from Institute of Microstructure Technology (IMT) / Karlsruhe Institute of Technology (KIT) that designs modular fluidic platforms using Shape Memory Alloy (SMA) miniature valves for user specific needs. It enables the realization of unprecedented fluidic platforms in terms of outer dimensions, functionality, integration density and power consumption. Uses of the technology range from laboratory based tools to commercial applications like medical diagnostics.Processes which are normally carried out in a lab can be miniaturized on a single chip and performed at the Point of Care/ Point of Need to enhance analysis, diagnostic efficiency and speed while reducing sample and reagent volumes. At the intersection of engineering, physics, chemistry, information technology, and biotechnology, memetis can revolutionize the way patients are diagnosed, monitored and treated. This solution has high disruptive potential and can be implemented across Europe and beyond to reach a large worldwide market.
Prototypes of various SMA miniature valves are already available. In the past year several pilot customers acquired paid developments and application-specific projects were transferred to series production (30,000 – 50,000 pieces). Currently, incoming 2018 orders are of low 6-digits providing a solid basis to achieve this year's turnover objective.
Our traction has already been substantial. Besides the EXIST Research Transfer Phase I grant, we have attracted equity investments and we have received the following awards: 1st place KIT Venture Fest Gründerpitch (Aug 2016), 1st place Elevator Pitch Baden-Württemberg (Jun 2017), Winner WECONOMY (Jun 2017), Init Innovation Prize Cyber Champions Award (Aug 2017), 2nd place CyberOne Hightech Award (Oct 2017) & 4th place at VC Pitch BW (Feb 2018). Further, we have qualified for the 2nd round of the CoHMed Connected Health
application process.
Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
